睡眠呼吸暂停在患有阿尔法-1抗素缺乏相关肺部疾病的人群中
Kristen E Holm1, Robert A Sandhaus1, Sheri Allison2
1AlphaNet, Inc, US; National Jewish Health, US.
Respiratory medicine
|June 23, 2025
概括
阻塞性睡眠呼吸暂停 (OSA) 在α-1抗素缺乏症 (AATD) 中很常见. 较低风险的AATD基因型显示出更高的OSA率,可能是由于吸烟和体重,而不是直接的AATD.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 睡眠医学 睡眠医学
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种与慢性阻塞性肺病 (COPD) 相关的遗传疾病.
- 阻塞性睡眠呼吸暂停 (OSA) 是肺部疾病患者常见的并发症.
- 了解AATD基因型和OSA之间的相互作用对于患者管理至关重要.
研究的目的:
- 为了调查阻塞性睡眠呼吸暂停 (OSA) 诊断,过度的嗜睡和OSA风险是否在不同的α-1抗素缺乏症 (AATD) 基因型之间有所不同.
- 探索AATD基因型与OSA患病率和严重程度之间的联系.
- 在AATD人群中确定可能导致OSA的潜在因素.
主要方法:
- 对1137名患有与AATD相关的肺部疾病的人进行了横截面调查.
- 多变量逻辑回归分析了AATD基因型与OSA诊断,过度嗜睡 (爱普沃思嗜睡量表) 和OSA风险 (STOP-BAG) 之间的关系.
- 奇平方测试评估了基因型之间的特征差异,如BMI.
主要成果:
- 超过31%的参与者被诊断为OSA.
- 与严重缺陷基因型 (ZZ,ZNull) (26.76%) 相比,具有低至中等风险的AATD基因型 (MZ,SZ) 个体的OSA诊断率更高 (39.76%).
- 低至中等风险的基因型也与过度嗜睡,肥胖 (BMI>35 kg/m2) 和大量吸烟 (≥40包年) 的更高率有关.
结论:
- 在患有与AATD相关的肺病的人群中,OSA非常普遍.
- 在OSA患病率的基因型特定差异可能会受到健康行为,如吸烟和体重管理的影响.
- 需要进一步的研究来确定AATD是否直接导致OSA风险.
相关概念视频
Sleep Apnea
225
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
225
Other Pulmonary Disorders
914
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
914
Acute Respiratory Failure-II
384
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
384
Physical Assessment of the Respiratory Tract II: Inspection
418
Physical assessment of the respiratory tract through inspection is a crucial step in understanding the patient's respiratory health. It provides insights into the functioning of the respiratory system, the musculoskeletal structure, and even the patient's nutritional status. This comprehensive approach involves observing several vital aspects: chest configuration, breathing patterns, respiratory rates, skin color, and use of accessory muscles.
Chest Configuration
The chest configuration...
Chest Configuration
The chest configuration...
418
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
327
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
327
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


